Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

PHASE3RecruitingINTERVENTIONAL
Enrollment

429

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

November 30, 2027

Conditions
Geographic Atrophy
Interventions
DRUG

Tinlarebant

5 mg tablet taken orally once a day

DRUG

Placebo

Placebo tablets for tinlarebant 5 mg prepared similarly.

Trial Locations (49)

100

RECRUITING

Belite Study Site, Taipei

1001

RECRUITING

Belite Study Site, Lausanne

2067

RECRUITING

Belite Study Site, Chatswood

2135

RECRUITING

Belite Study Site, Strathfield

3002

RECRUITING

Belite Study Site, East Melbourne

4031

RECRUITING

Belite Study Site, Basel

4101

RECRUITING

Belite Study Site, Brisbane

5000

RECRUITING

Belite Study Site, Adelaide

6009

RECRUITING

Belite Study Site, Crawley

10005

NOT_YET_RECRUITING

Belite Study Site, Beijing

11590

RECRUITING

Belite Study Site, Westbury

14000

RECRUITING

Belite Study Site, Prague

14059

RECRUITING

Belite Study Site, Prague

15143

RECRUITING

Belite Study Site, Sewickley

19107

RECRUITING

Belite Study Site, Philadelphia

20186

RECRUITING

Belite Study Site, Warrenton

21000

RECRUITING

Belite Study Site, Dijon

21740

RECRUITING

Belite Study Site, Hagerstown

27511

RECRUITING

Belite Study Site, Cary

27587

RECRUITING

Belite Study Site, Wake Forest

27710

RECRUITING

Belite Study Site, Durham

33305

RECRUITING

Belite Study Site, Taoyuan District

33805

NOT_YET_RECRUITING

Belite Study Site, Lakeland

38138

RECRUITING

Belite Study Site, Germantown

40447

RECRUITING

Belite Study Site, Taichung

55416

RECRUITING

Belite Study Site, Saint Louis Park

69130

RECRUITING

Belite Study Site, Écully

69317

RECRUITING

Belite Study Site, Lyon

70852

RECRUITING

Belite Study Site, Ostrava

75231

NOT_YET_RECRUITING

Belite Study Site, Dallas

78240

RECRUITING

Belite Study Site, San Antonio

79606

RECRUITING

Belite Study Site, Abilene

85020

RECRUITING

Belite Study Site, Phoenix

90033

RECRUITING

Belite Study Site, Los Angeles

90211

RECRUITING

Belite Study Site, Beverly Hills

91007

NOT_YET_RECRUITING

Belite Study Site, Arcadia

92093

RECRUITING

Belite Study Site, San Diego

92467

RECRUITING

Belite Study Site, Huntington Beach

94303

RECRUITING

Belite Study Site, Palo Alto

97239

RECRUITING

Belite Study Site, Portland

100044

RECRUITING

Belite Study Site, Beijing

100730

RECRUITING

Belite Study Site, Beijing

130008

RECRUITING

Belite Study Site, Marseille

325027

NOT_YET_RECRUITING

Belite Study Site, Zhejiang

510060

RECRUITING

Belite Study Site, Guandong

610093

RECRUITING

Belite Study Site, Chengdu

NR31 6LA

RECRUITING

Belite Study Site, Great Yarmouth

HA1 3UJ

RECRUITING

Belite Study Site, Harrow

EC1V 2PD

RECRUITING

Belite Study Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Belite Bio, Inc

INDUSTRY

NCT05949593 - Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy | Biotech Hunter | Biotech Hunter